Current situation for generic drugs in Japan

Journal of Generic Medicines

Volumn 2, Issue 3, 2005, Pages 219-231

  Riku, Juichi ^a  

^a SAWAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Generics share; Japan; Medical cost; Obstacles; Price gap margin; Reimbursement drug price

Indexed keywords

ADALART L; AMLODIN; AMLODIPINE BESYLATE; ATORVASTATIN; DONEPEZIL; FAMOTIDINE; GENERIC DRUG; ITRACONAZOLE; LANSOPRAZOLE; LEUPRORELIN; LEVOFLOXACIN; NIFEDIPINE; NU LOTAN; PAROXETINE; PRAVASTATIN; RECOMBINANT ERYTHROPOIETIN; TAMSULOSIN; TERBINAFINE; VOGLIBOSE;

ARTICLE; COST CONTROL; DRUG APPROVAL; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; DRUG QUALITY; GERMANY; HEALTH CARE ACCESS; HEALTH CARE COST; HUMAN; JAPAN; MEDICAL FEE; NATIONAL HEALTH INSURANCE; PATENT; PHARMACEUTICAL CARE; PRESCRIPTION; PROFIT; PROSPECTIVE PAYMENT; PROSPECTIVE PRICING; REFERENCE VALUE; REIMBURSEMENT; UNITED KINGDOM; UNITED STATES;

EID: 17844362688     PISSN: 17411343     EISSN: None     Source Type: Journal    
DOI: 10.1057/palgrave.jgm.4940073     Document Type: Article

References (15)

1. Ministry of Health, Labor and Welfare (MHLW) (2004) 'National Medical Expenditures 2002 in Japan', available at www.mhlw.go.ip/tonkei/saikin/hw/k-iryohi/02/index/html (in Japanese), accessed 13th January, 2005.
2. OECD (2004), 'OECD Health Data 2004', available at www.databeuro.com/acatalog/health/key_healthdata2004.pdf, accessed 13th January, 2005.
3. EPMA (2003), 'Generics share', available at http://www.epma.gr.jp/environment03.htm (in Japanese), accessed 13th January.
4. Redwood, H. (2004) 'Innovation - Patents, generics and payers: The political dynamics of interaction', Journal of Generic Medicines, Vol. 1, No. 3, pp. 249-258.
5. Mita, M. and Muraoka, S. (2002) 'Generic drugs: Forward wings but high hurdles too', Morgan Stanley Healthcare, 7th November.
6. London School of Economics (2001) 'LSE study on healthcare in individual countries: Japan', available at www.pharmacos.eudra.org/F3/g10/docs/tse/Japan.pdf, accessed 13th January, 2004.
7. MHLW (2003) 'Market Survey September 2001' (in Japanese). See also www.egagenerics.com/fac-pricing.
8. Anon. (2004) Scrip, Vol. 2933, 10th March, p.22.
9. Anon. (2004) Scrip, Vol. 2957/58, 2nd June, p.22.
10. Anon. (2004) Scrip, Vol. 2972, 23rd July, p.16.
11. Onozuka, M. and Kato, Y. (2004) 'Q-Series: Will generics take off in Japan', UBS Investment Research, 9th July, pp. 1-44.
12. Anon. (2003) Scrip, Vol. 2895, 22nd October, p. 16.
13. Anon. (2004) Scrip, Vol. 2960, 11th June, p.18.
14. Anon. (2004) Scrip, Vol. 2947, 28th April, p.18.
15. Anon. (2003) 'Pharma Japan Handbook' Jiho Inc, Tokyo, Japan pp. 13-19.